US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist
  • 3.820
  • -0.240-5.91%
Close Dec 20 16:00 ET
  • 3.820
  • 0.0000.00%
Post 20:01 ET
38.73MMarket Cap-4.20P/E (TTM)

Grace Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Grace Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Grace Therapeutics Earnings Reports

  • Grace Therapeutics | 8-K: Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update

    Nov 13 21:02

  • Grace Therapeutics | 10-Q: Q2 2025 Earnings Report

    Nov 13 20:33

  • Acasti Pharma | 8-K: Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update

    Aug 9 20:02

  • Acasti Pharma | 10-Q: Q1 2025 Earnings Report

    Aug 9 19:32

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data